BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 16397214)

  • 21. AZGP1 is a tumor suppressor in pancreatic cancer inducing mesenchymal-to-epithelial transdifferentiation by inhibiting TGF-β-mediated ERK signaling.
    Kong B; Michalski CW; Hong X; Valkovskaya N; Rieder S; Abiatari I; Streit S; Erkan M; Esposito I; Friess H; Kleeff J
    Oncogene; 2010 Sep; 29(37):5146-58. PubMed ID: 20581862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.
    Simiantonaki N; Jayasinghe C; Michel-Schmidt R; Peters K; Hermanns MI; Kirkpatrick CJ
    Int J Oncol; 2008 Mar; 32(3):585-92. PubMed ID: 18292935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial growth factor C stimulates progression of human gastric cancer via both autocrine and paracrine mechanisms.
    Kodama M; Kitadai Y; Tanaka M; Kuwai T; Tanaka S; Oue N; Yasui W; Chayama K
    Clin Cancer Res; 2008 Nov; 14(22):7205-14. PubMed ID: 19010837
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of vascular endothelial growth factor receptors on tumor cells in head and neck squamous cell carcinoma.
    Lalla RV; Boisoneau DS; Spiro JD; Kreutzer DL
    Arch Otolaryngol Head Neck Surg; 2003 Aug; 129(8):882-8. PubMed ID: 12925349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epithelial-mesenchymal transition (EMT) and activated extracellular signal-regulated kinase (p-Erk) in surgically resected pancreatic cancer.
    Javle MM; Gibbs JF; Iwata KK; Pak Y; Rutledge P; Yu J; Black JD; Tan D; Khoury T
    Ann Surg Oncol; 2007 Dec; 14(12):3527-33. PubMed ID: 17879119
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesenchymal transformation in epithelial ovarian tumor cells expressing epidermal growth factor receptor variant III.
    Zeineldin R; Rosenberg M; Ortega D; Buhr C; Chavez MG; Stack MS; Kusewitt DF; Hudson LG
    Mol Carcinog; 2006 Nov; 45(11):851-60. PubMed ID: 16788982
    [TBL] [Abstract][Full Text] [Related]  

  • 27. c-erbB2-induced epithelial-mesenchymal transition in mammary epithelial cells is suppressed by cell-cell contact and initiated prior to E-cadherin downregulation.
    Jenndahl LE; Isakson P; Baeckström D
    Int J Oncol; 2005 Aug; 27(2):439-48. PubMed ID: 16010426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. KCl cotransporter-3 down-regulates E-cadherin/beta-catenin complex to promote epithelial-mesenchymal transition.
    Hsu YM; Chen YF; Chou CY; Tang MJ; Chen JH; Wilkins RJ; Ellory JC; Shen MR
    Cancer Res; 2007 Nov; 67(22):11064-73. PubMed ID: 18006853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells.
    Veveris-Lowe TL; Lawrence MG; Collard RL; Bui L; Herington AC; Nicol DL; Clements JA
    Endocr Relat Cancer; 2005 Sep; 12(3):631-43. PubMed ID: 16172196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endothelin-1 is required during epithelial to mesenchymal transition in ovarian cancer progression.
    Rosanò L; Spinella F; Di Castro V; Decandia S; Nicotra MR; Natali PG; Bagnato A
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1128-31. PubMed ID: 16741062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interactions between sphingosine-1-phosphate and vascular endothelial growth factor signalling in ML-1 follicular thyroid carcinoma cells.
    Balthasar S; Bergelin N; Löf C; Vainio M; Andersson S; Törnquist K
    Endocr Relat Cancer; 2008 Jun; 15(2):521-34. PubMed ID: 18509004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells.
    Chiu ST; Chang KJ; Ting CH; Shen HC; Li H; Hsieh FJ
    Carcinogenesis; 2009 Sep; 30(9):1475-86. PubMed ID: 19483190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice.
    Strizzi L; Bianco C; Normanno N; Seno M; Wechselberger C; Wallace-Jones B; Khan NI; Hirota M; Sun Y; Sanicola M; Salomon DS
    J Cell Physiol; 2004 Nov; 201(2):266-76. PubMed ID: 15334661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characterization of TGFbeta-induced epithelial-mesenchymal transition in normal finite lifespan human mammary epithelial cells.
    Lindley LE; Briegel KJ
    Biochem Biophys Res Commun; 2010 Sep; 399(4):659-64. PubMed ID: 20691661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of E-cadherin-dependent and -independent events in a new model of c-Fos-mediated epithelial-mesenchymal transition.
    Mejlvang J; Kriajevska M; Berditchevski F; Bronstein I; Lukanidin EM; Pringle JH; Mellon JK; Tulchinsky EM
    Exp Cell Res; 2007 Jan; 313(2):380-93. PubMed ID: 17141758
    [TBL] [Abstract][Full Text] [Related]  

  • 36. VEGF and VEGFR-1 are coexpressed by epithelial and stromal cells of renal cell carcinoma.
    Rivet J; Mourah S; Murata H; Mounier N; Pisonero H; Mongiat-Artus P; Teillac P; Calvo F; Janin A; Dosquet C
    Cancer; 2008 Jan; 112(2):433-42. PubMed ID: 18041056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer.
    Wu Y; Zhong Z; Huber J; Bassi R; Finnerty B; Corcoran E; Li H; Navarro E; Balderes P; Jimenez X; Koo H; Mangalampalli VR; Ludwig DL; Tonra JR; Hicklin DJ
    Clin Cancer Res; 2006 Nov; 12(21):6573-84. PubMed ID: 17085673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tyrosine kinase receptor RON in human pancreatic cancer: expression, function, and validation as a target.
    Camp ER; Yang A; Gray MJ; Fan F; Hamilton SR; Evans DB; Hooper AT; Pereira DS; Hicklin DJ; Ellis LM
    Cancer; 2007 Mar; 109(6):1030-9. PubMed ID: 17311308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical expression of vascular endothelial growth factor and vascular endothelial growth factor receptor associated with tumor cell proliferation in canine cutaneous squamous cell carcinomas and trichoepitheliomas.
    Al-Dissi AN; Haines DM; Singh B; Kidney BA
    Vet Pathol; 2007 Nov; 44(6):823-30. PubMed ID: 18039895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cooperative signaling between oncostatin M, hepatocyte growth factor and transforming growth factor-β enhances epithelial to mesenchymal transition in lung and pancreatic tumor models.
    Argast GM; Mercado P; Mulford IJ; O'Connor M; Keane DM; Shaaban S; Epstein DM; Pachter JA; Kan JL
    Cells Tissues Organs; 2011; 193(1-2):114-32. PubMed ID: 21041998
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.